WILMINGTON, N.C., Jan. 23 /PRNewswire-FirstCall/ -- aaiPharma Inc.
(Nasdaq: AAII) announced today that Dr. Philip S. Tabbiner, President and
Chief Executive Officer of aaiPharma, will be presenting at the Piper Jaffray
16th Annual Health Care Conference in New York on Wednesday, January 28, 2004
at 12:00 p.m. (ET).
The presentation will be broadcast live over the Internet, then archived
and available for 10 days following the event. The web cast will be accessible
through the Company's website at http://www.aaipharma.com .
About aaiPharma
aaiPharma Inc. is a leading, science-based pharmaceutical company focused
on pain management, with corporate headquarters in Wilmington, North Carolina.
With more than 24 years of drug development expertise and a proven sales and
marketing track record, the Company is focused on developing, acquiring, and
marketing well-known, branded medicines in its targeted therapeutic areas.
aaiPharma's development efforts are focused on developing improved medicines
from established molecules through its significant research and development
capabilities. For more information on the Company, including its product
development organization AAI Development Services, please visit aaiPharma's
website at http://www.aaipharma.com .
SOURCE aaiPharma Inc.
 back to top
Related links:
http://www.aaipharma.com
CONTACT:
Investors, James B. Sloan, Jr., Senior Vice
President, Corporate Finance of aaiPharma Inc., +1-910-254-7690
|
